BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 8, 2020
View Archived Issues
Minimal phenotyping gives minimal insights into MDD genetics
Read More
Stopping tau in its tracks
Read More
Phase IIa study of golexanolone shows no clinical benefit
Read More
FDA approves the initiation of stem cell study for protection against COVID-19
Read More
CellCentric enters agreement with PCCTC for phase II dose-expansion study of CCS-1477
Read More
Catalyst announces pivotal phase III design for MarzAA
Read More
Researchers in Montreal and NYU partner on new COVID-19 clinical study
Read More
IXT-v100 vaccine decreases meth-taking and -seeking behaviors in vivo
Read More
Preclinical data support development of WZ-66 for NASH
Read More
Roche patents Toll-like receptor antagonists
Read More
Beijing Yuezhikangtai Biomedicines discloses VEGFR inhibitors
Read More
Forge Therapeutics presents new bacterial LpxC inhibitors
Read More
Investigator-initiated IND application filed to study CORVax12 to prevent COVID-19
Read More
New USP9X inhibitors identified by FORMA Therapeutics
Read More
Biogen describes new OGA inhibitors
Read More
New nitrofuran-class antibiotic IITR-06144 shows efficacy against resistant bacteria
Read More
FDA clears Polaryx's IND for PLX-200 in juvenile neuronal ceroid lipofuscinosis
Read More
Emapalumab and anakinra studied to reduce hyperinflammation and respiratory distress in COVID-19
Read More
Kolon begins first-in-human study of KLS-2031 for neuropathic pain from lumbosacral radiculopathy
Read More
Selective circadian regulation may yield new therapies
Read More
New HDAC6 inhibitors show promise in Charcot-Marie-Tooth disease cell model
Read More
GPR56 found to be tied with antidepressant treatment response
Read More
Viriom opens phase II study of NNRTI elsulfavirine for COVID-19
Read More